INSIDER Law
Featured on INSIDER Law
Trade groups irked with FDA following CBD report to Congress
Supplement RegulationsTrade groups irked with FDA following CBD report to CongressTrade groups irked with FDA following CBD report to Congress
FDA’s 15-page report to the House and Senate appropriations committees was met with criticism from some leaders in the natural products and hemp industries, who have said the agency is dragging its heels on actively regulating a hemp-derived compound that has proliferated in U.S. products marketed as dietary supplements.
More from INSIDER Law